What is he best known for?
The fields of study he is best known for:
- Gene
- Immune system
- Cancer
His main research concerns Immunology, Indoleamine 2,3-dioxygenase, T cell, Immune system and Cell biology.
His Immunotherapy, Immune tolerance, Antigen and Antigen-presenting cell study, which is part of a larger body of work in Immunology, is frequently linked to Population, bridging the gap between disciplines.
His Indoleamine 2,3-dioxygenase research includes elements of Dendritic cell, Immunosuppression, Melanoma, Dioxygenase and FOXP3.
His T cell study incorporates themes from Inflammation, Receptor, Cancer research and Fetus.
His Immune system research is multidisciplinary, incorporating perspectives in Myeloid and Tumor progression, Cancer.
In Cell biology, he works on issues like CD28, which are connected to Interferon gamma and Enzyme activator.
His most cited work include:
- Prevention of allogeneic fetal rejection by tryptophan catabolism (2134 citations)
- IDO expression by dendritic cells: tolerance and tryptophan catabolism. (1826 citations)
- INHIBITION OF T CELL PROLIFERATION BY MACROPHAGE TRYPTOPHAN CATABOLISM (1256 citations)
What are the main themes of his work throughout his whole career to date?
David H. Munn mainly focuses on Immunology, Immune system, Indoleamine 2,3-dioxygenase, Cancer research and T cell.
His study in Immunology is interdisciplinary in nature, drawing from both Cytotoxic T cell and Cell biology.
His Immune system research is multidisciplinary, incorporating elements of Inflammation, Proinflammatory cytokine and Cancer.
His Indoleamine 2,3-dioxygenase research includes themes of Acquired immune system, Dendritic cell, Immunosuppression, CpG Oligodeoxynucleotide and Kynurenine.
His Melanoma study in the realm of Cancer research interacts with subjects such as Population.
The T cell study combines topics in areas such as Biochemistry and Transplantation.
He most often published in these fields:
- Immunology (65.31%)
- Immune system (38.01%)
- Indoleamine 2,3-dioxygenase (30.63%)
What were the highlights of his more recent work (between 2015-2021)?
- Cancer research (25.83%)
- Immune system (38.01%)
- Immunology (65.31%)
In recent papers he was focusing on the following fields of study:
David H. Munn focuses on Cancer research, Immune system, Immunology, Immunotherapy and T cell.
He interconnects Inflammation, Transcription factor, Cytokine and Indoleamine 2,3-dioxygenase in the investigation of issues within Immune system.
The concepts of his Indoleamine 2,3-dioxygenase study are interwoven with issues in Kynurenine and Antigen-presenting cell.
His Immunology study integrates concerns from other disciplines, such as Carcinogenesis and Melanoma.
The study incorporates disciplines such as Tumor necrosis factor alpha, Molecular biology and Antigen in addition to Immunotherapy.
His research in T cell intersects with topics in Haematopoiesis, Effector, Cell biology and CD8.
Between 2015 and 2021, his most popular works were:
- IDO in the Tumor Microenvironment: Inflammation, Counter-Regulation, and Tolerance (414 citations)
- Immune suppressive mechanisms in the tumor microenvironment (247 citations)
- STING Promotes the Growth of Tumors Characterized by Low Antigenicity via IDO Activation (112 citations)
In his most recent research, the most cited papers focused on:
- Gene
- Immune system
- Cancer
David H. Munn spends much of his time researching Immunology, Immune system, Cancer research, Tumor microenvironment and Immunotherapy.
His Immunology study often links to related topics such as Carcinogenesis.
He has included themes like Inflammation, Transcription factor and Indoleamine 2,3-dioxygenase in his Immune system study.
His work is dedicated to discovering how Cancer research, Proinflammatory cytokine are connected with Small interfering RNA and Macrophage polarization and other disciplines.
Within one scientific family, David H. Munn focuses on topics pertaining to T cell under Tumor microenvironment, and may sometimes address concerns connected to LRP6, Frizzled, LRP5 and Wnt signaling pathway.
His Immunotherapy research incorporates themes from Myeloid and Antigen-presenting cell.
This overview was generated by a machine learning system which analysed the scientist’s
body of work. If you have any feedback, you can
contact us
here.
